Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions
Authors
Keywords
DNA methylation, Methylation, Biomarkers, Cancer detection and diagnosis, Cytology, Pleural effusion, Polymerase chain reaction, Lung and intrathoracic tumors
Journal
PLoS One
Volume 8, Issue 12, Pages e84225
Publisher
Public Library of Science (PLoS)
Online
2013-12-28
DOI
10.1371/journal.pone.0084225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interplay between the Cancer Genome and Epigenome
- (2013) Hui Shen et al. CELL
- Treatment of Complicated Pleural Effusions in 2013
- (2013) Rahul Bhatnagar et al. CLINICS IN CHEST MEDICINE
- Pleural effusions
- (2013) José M. Porcel et al. DM DISEASE-A-MONTH
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Epigenetic Reprogramming in Cancer
- (2013) M. L. Suva et al. SCIENCE
- DNA methylation biomarkers and their utility for solid cancer diagnostics
- (2012) Karen A. Heichman et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- DNA Methylation of the Homeobox Genes PITX2 and SHOX2 Predicts Outcome in Non–small-cell Lung Cancer Patients
- (2012) Dimo Dietrich et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- Correlation of SHOX2 Gene Amplification and DNA Methylation in Lung Cancer Tumors
- (2011) Katja U Schneider et al. BMC CANCER
- Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions
- (2011) Do-Sim Park et al. CLINICAL & EXPERIMENTAL METASTASIS
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
- (2010) Bernd Schmidt et al. BMC CANCER
- Lung Injury Following Thoracoscopic Talc Insufflation
- (2010) Anne V. Gonzalez et al. CHEST
- Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions
- (2010) Marc Tänzer et al. PLoS One
- Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
- (2010) M. E. Roberts et al. THORAX
- A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling
- (2009) Christoph Kneip et al. BIOTECHNIQUES
- Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
- (2009) T. deVos et al. CLINICAL CHEMISTRY
- Frequently Methylated Tumor Suppressor Genes in Head and Neck Squamous Cell Carcinoma
- (2008) K. L. Bennett et al. CANCER RESEARCH
- Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
- (2008) Robert Grützmann et al. PLoS One
- Soluble Mesothelin-Related Peptide Level Elevation in Mesothelioma Serum and Pleural Effusions
- (2007) Harvey I. Pass et al. ANNALS OF THORACIC SURGERY
- DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
- (2007) C. Lofton-Day et al. CLINICAL CHEMISTRY
- Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis
- (2007) Q-L Liang et al. THORAX
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started